2024 CCC Symposium Call for Abstracts

Abstract Submission Details

Session Information

The CCC Planning Committee invites abstract submissions from any person or organization wishing to present a:

• Program/Research Showcase Session (1 hour)
• Program/Research Roundtable Discussion (45 minutes)
• Poster Session

Required Inclusions

1. Focused content and populations:

Content areas may include:

• Behavioral Health
• Cancer Control
• Climate Change and Health
• Community Engagement & Partnerships
• Community Health
• Diversity and Health Equity
• Emergency Preparedness & Response
• Environmental Health & the Built Environment
• Financial Toxicity
• Food and Nutrition
• Homelessness & Housing
• Maternal, Child & Adolescent Health
• Physical Activity
• Oncology Health Education & Health Promotion
• Oncology Health Nursing
• Oncology Health Policy/Law
• Oncology Health Workforce
• Pharmacological Care
• Prevention
• Prevention in Primary Care Settings
• Screening
• Specialty Care
• Specialty Care in Primary Care Settings (DDS, OD, RD, PharmD, etc.)
• Technology
• Tobacco Prevention and Control
• Workforce Development & Resiliency
• Other

Population areas may include:

• Aging
• LGBTQ+
• Intersectional (select if 2 or more populations represented)
• Men
• Military & Veteran
• Pediatric
• Racial & Ethnic Minorities
• Refugee & Immigrant
• Rural
• Women
• Other

2. How the presentation/poster relates to the theme of the conference – Navigating the Journey from Screening to Survival: Redefining the Cancer Roadmap. Focus on what you have accomplished and how you will move forward. Describe your next steps and plans for future work. Describe how your work impacts health equity or what mitigating strategies you are using to ensure disparities do not increase (for example, introducing new treatment or technology that would leave certain populations behind).
3. As a state that is proud of our diverse background, geography, and economy, your submission should reflect the coalition’s commitment to health equity.

Submission Options

• Program/Research Showcase Session (1 hour): 1-hour Program/Research Showcase Sessions are intended to provide attendees with an in-depth presentation and discussion opportunities, featuring a successful practice, program, or research on key issues. This session differs from a 45-minute Program/Research Roundtable Session in that presenters are expected to engage participants in interactive learning activities and discussions. Presenters should plan to leave at least 15 minutes for interactive discussion between the audience and panel members.
• Program/Research Roundtable Discussion (45 minutes): These sessions are intended to provide participants with the ability to discuss topics shared by the presenter in an informal atmosphere that encourages engagement with the presenter and other participants. Presenters should prepare for a 15-minute presentation and 30 minutes of discussion. Large screens or A/V will not be available for these presentations. Presenters are welcome to use personal computers or handouts for participants.
• Poster Session: Poster Sessions are intended to provide a presentation of a program or research findings by displaying graphs, photos, diagrams, and descriptive text. The authors will then hold discussions with the registrants who are circulating among the poster boards during the designated poster session time frame. The presenter should remain by their poster board for the duration of the one-hour session(s) to answer questions.

Please Note: Acceptance to present requires all presenters to register and pay to attend the conference.

Submission Instructions

We welcome submissions from all over the county/internationally. Presentations do not have to be Colorado specific but should reflect current best practices and be applicable to the residents of the state of Colorado.

Complete and submit the online form; one submission per presentation. You will be able to stop and complete your abstract submission at a later time. Please ensure the abstract is submitted completely, indicated by a completion message and abstract submission summary email immediately following the submission. The lead presenter will receive a confirmation of receipt. Once submitted, revisions to abstracts cannot be accepted. Late submissions will not be accepted. Communication will be directed to the lead presenter only. Call for abstracts closes on October 15, 2023 at 5 p.m. MT. You will receive notice of your acceptance/rejection status by early December 2023.

Your abstract submission must clearly state the:

• Presentation Title
• Presenters (up to 6, one lead and five co-presenters) and Contact Information (Name, job title or role (e.g., student), organization, address, phone number, email address, and headshot) *All communication regarding presentations will be sent to the lead presenter only.
• Lead Presenter’s and Additional Presenters’ Biographies and Credentials (word limit 500)
  • Include if you are a member of any CCC Task Forces or Regional Cancer Networks

• Preferred Session Format ( 1-hour Program/Research Showcase, 45-minute Program/Research Roundtable, Poster). Indicate if you are willing to participate in other formats if you are not chosen for your preferred format.
• Learning Objectives of Session (up to 3). Describe, in measurable terms using a behavioral verb (such as describe, discuss, explain), what attendees will be able to do following participation in the session. The learning objectives should provide a clear focus for your session. Session objectives will be used to inform the evaluation. Words to avoid: understand, know, learn.
• Abstract Text:

• • Program/Research Showcase Session: In 300 words or less, clearly describe why your submission is relevant to oncology or cancer professionals and to the theme of the conference. Include the following information:

• • • Background/Purpose: Present main research questions, hypothesis, needs.
    • Methods: Include descriptions of participants, procedures, instrumentation, data analysis, or the equivalent.
    • Results: Include the results of any research related to the presentation.
    • Implications: Clearly present the “take home messages” from your investigation as it relates to cancer or the social determinants that relate to life pre- or post-disease.
    • How you plan to facilitate attendee interaction and discussion.  

• • Roundtable Discussion: In 300 words or less, clearly describe the main topic or question to be posed in your roundtable session, the content that will be covered, why this topic is important for discussion, and why the session would be relevant to oncology or cancer professionals and the theme of the conference.  Clearly present the “take home messages” from your investigation as it relates to cancer or the social determinants that relate to life pre- or post-disease.

• • Poster Session: In 300 words or less, clearly describe why your submission is relevant to oncology or cancer professionals and the theme of the conference––as you consider what you have accomplished, how will you move forward. What are your hopes for this work in the future?  Include the following information in your poster submission:

• • • Background/Purpose: Present main research questions, hypothesis, needs.
    • Methods: Include descriptions of participants, procedures, instrumentation, data analysis, or the equivalent.
    • Results: Results presented in the poster can be preliminary, incomplete (in process of data collection), and can include anticipated or speculated results.
    • Implications: Clearly present the “take home messages” from your investigation as it relates to cancer or the social determinants that relate to life pre- or post-disease.

• Brief Description of Session or track best suited for the conference program (3-5 sentences)
• Tracks may include: Clinical, Palliative care & Survivorship, DEI, Screening and Early Detection, Treatment/clinical trials 
• Level of Session Content/Skill Level

• • Introductory
  • Intermediate
  • Advanced

• How the presentation relates to the 2021-2025 Colorado Cancer Plan’s 6 Focus areas: Must select at least one.
  • Prevention: Encourage healthy behaviors and a less harmful environment to lower the risk of cancer.
  • Screening: Promote the benefits and increased coverage of appropriate screening tests to ensure early and effective diagnosis.
  • Diagnosis and Treatment: Reduce the barriers to early diagnosis and treatment, ensure best practices and encourage participation in clinical trials.
  • Survivorship and End-Of-Life Care: Ensure services and resources necessary to support the continued physical and mental health of a growing number of cancer survivors.
  • Cross-Cutting: Support the integration and training of patient navigators and community health workers and promote awareness of available insurance coverage.
  • Diversity and Inclusion: Provide programs or resources that support diversity, equity and inclusion

• Audio/Visual Needs
• Special accommodations for presenter(s)/presentation